You are here: Industry Insights > Insulin

News List

Congressman aims to break pharma’s insulin ‘pricing monopoly’ by legalizing Canadian imports fiercepharma
February 24, 2019
U.S. legislators have been introducing bills left and right proposing a variety of methods for bringing down drug prices. Now, Vermont's congressman is zeroing in on a specific class of diabetes medicines that he says have become far too expensive: insuli
Abbott and Novo Nordisk enter partnership to provide integrated digital solution to people with diabetes using insulin worldpharmanews
February 21, 2019
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk...
New pill can deliver insulin worldpharmanews
February 12, 2019
An MIT-led research team has developed a drug capsule that could be used to deliver oral doses of insulin, potentially replacing the injections that people with type 2 diabetes have to give themselves every day.
Committee demands answers on rising cost of insulin in the US europeanpharmaceuticalreview
February 02, 2019
Letters have been sent to Eli Lilly, Novo Nordisk and Sanofi asking them to explain the rapidly increasing cost of insulin…
Insulin Price More Than Doubled in the United States drugs
January 24, 2019
Some Americans with type 1 diabetes have cut back on their insulin usage as the cost of the drug nearly doubled over a five-year period.....
Regenerating insulin-producing cells with zinc could tackle the underlying cause of diabetes fiercebiotech
December 28, 2018
Most current diabetes treatments, from insulin injections to newer GLP-1 agonists, don’t solve the underlying cause of the disease. The ability to regenerate insulin-producing cells in the pancreas would do the job.....
Mylan announces victory over Sanofi in Lantus patent claims pharmaceutical-technology
December 17, 2018
Generic drug maker Mylan has announced that the US Patent and Trademark Appeal Board (PTAB) invalidated Sanofi’s patent infringement claims over insulin drug Lantus......
Mylan says Sanofi loses Lantus insulin patent claims expressbpd
December 14, 2018
Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and paediatric patients with type 1 diabetes to control high blood sugar
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus fiercepharma
December 14, 2018
Sanofi’s Lantus is already facing off against generic competition from Eli Lilly and Boehringer’s Basaglar, but now Mylan is adding to the pressure by prevailing in a patent challenge at the U.S. Patent and Trademark Office.
FDA Commissioner Scott Gottlieb blasts insulin pricing, unveils move to bolster biosimilar competition fiercepharma
December 14, 2018
As drug prices climb and the Trump administration works over ways to lower them, FDA commissioner Scott Gottlieb, M.D., has homed in on insulin prices as his agency's next target.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page